Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caphosol for Oral Mucositis Prevention in Pediatric Cancer Patients
NCT02807337Phase 2Completed
- Sponsor
- Tampere University Hospital
- Start
- Aug 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of supersaturated calcium phosphate rinse in oral mucositis (OM) (2 arms), sponsored by Tampere University Hospital. Primary endpoints: Children International Mucositis Evaluation Scale at 14 days and World Health Organization oral mucositis scale at 14 days. Started Aug 2016; status: completed.
02
Drugs
supersaturated calcium phosphate rinse
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02807337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807337.